Patents Assigned to CURE PHARMACEUTICAL HOLDING CORP.
  • Publication number: 20220047504
    Abstract: An oral dissolvable film, methods of making the oral dissolvable film, and methods of using the oral dissolvable film. The oral dissolvable film contains pores located therein.
    Type: Application
    Filed: May 27, 2021
    Publication date: February 17, 2022
    Applicant: Cure Pharmaceutical Holding Corp.
    Inventors: Robert Davidson, Steven Ruhl, Vered Gigi, Bhaumik Patel, Jose Bernardo, Maribel Espinoza
  • Publication number: 20220023198
    Abstract: The present invention relates to an oral soluble film (OSF), methods of orally administering the same, and methods of manufacturing the same. The oral soluble film includes sildenafil citrate, and can further include a binder, filler, flavoring agent, plasticizer, sweetening agent, preservative, solvent, and optionally coloring agent. The active ingredient and excipients can be provided and present in an amount effective to achieve desired physical and performance characteristics of the OSF.
    Type: Application
    Filed: September 29, 2021
    Publication date: January 27, 2022
    Applicant: CURE Pharmaceutical Holding Corp.
    Inventors: Maribel Espinoza, Vered Gigi
  • Patent number: 11160292
    Abstract: An protein-polysaccharide macromolecular complex article of manufacture containing encapsulated ethyl alcohol and/or other spirits serving as an entertaining and novel non-beverage method of consuming alcohol. The article of manufacture encapsulates ethyl alcohol and/or other spirits in the amorphous regions of the complex macromolecular structure releasing it only upon chewing and exposure to the environment of the oral cavity. The article of manufacture is stable and capable of retaining shape and form for extended periods of time at ambient temperature allowing for relatively low-cost commercial manufacture and distribution.
    Type: Grant
    Filed: September 4, 2019
    Date of Patent: November 2, 2021
    Assignee: Cure Pharmaceutical Holding Corp.
    Inventors: Margaret Teresa Thomas Virgallito, Joshua Alan Held
  • Publication number: 20210322306
    Abstract: The present invention relates to an oral dissolvable film (ODF), methods of orally administering the same, and methods of manufacturing the same. The ODF includes a high load of binder. Such an ODF, containing a high load of binder, can achieve the requisite physical and performance characteristics and can be manufactured on a commercial scale, while demonstrating that the ODF is safe and effective to consumers for its intended use. This also includes formulating and configuring the ODF to deliver the API as desired, via, e.g., enteral, transmucosal, sublingual, and/or buccal, when the administration is oral.
    Type: Application
    Filed: April 21, 2021
    Publication date: October 21, 2021
    Applicant: CURE Pharmaceutical Holding Corp.
    Inventors: Maribel Espinoza, Vered Gigi, Armen Pirjanian
  • Publication number: 20210275618
    Abstract: Provided herein is a method of obtaining an extract from a plant biomass as well as an extract obtained from the method. Also provided is a pharmaceutical product, ODF, nutraceutical product, and/or edible product, that includes the extract and one or more excipients. Also provided is a method that includes orally administering the extract (or pharmaceutical product, ODF, nutraceutical product, and/or edible product, that includes the extract).
    Type: Application
    Filed: March 5, 2021
    Publication date: September 9, 2021
    Applicant: CURE Pharmaceutical Holding Corp.
    Inventors: Robert Davidson, Vered Gigi, Jose Bernardo
  • Publication number: 20210145849
    Abstract: The present invention relates to an oral dissolvable film (ODF) containing an active ingredient (e.g., vitamin D) that is, outside of the ODF, relatively unstable to at least one of heat, light, moisture, and oxygen. The present invention also relates to methods of manufacturing and using the same.
    Type: Application
    Filed: September 30, 2020
    Publication date: May 20, 2021
    Applicant: CURE PHARMACEUTICAL HOLDING CORP.
    Inventors: Maribel Espinoza, Jose Bernardo
  • Publication number: 20200246405
    Abstract: The present invention provides for methods of obtaining an extract of Cannabis plant material as well as subsequent processing of the extract to provide a concentrate of Cannabis. The present invention also provides for pharmaceutical dosage forms (e.g., oral thin films and transdermal patches) that include the concentrate (or extract) of Cannabis, as well as methods of medical treatment that include administering the pharmaceutical dosage forms.
    Type: Application
    Filed: April 23, 2020
    Publication date: August 6, 2020
    Applicant: CURE PHARMACEUTICAL HOLDING CORP.
    Inventor: Gary J. Speier
  • Publication number: 20200246406
    Abstract: The present invention provides for methods of obtaining an extract of Cannabis plant material as well as subsequent processing of the extract to provide a concentrate of Cannabis. The present invention also provides for pharmaceutical dosage forms (e.g., oral thin films and transdermal patches) that include the concentrate (or extract) of Cannabis, as well as methods of medical treatment that include administering the pharmaceutical dosage forms.
    Type: Application
    Filed: April 23, 2020
    Publication date: August 6, 2020
    Applicant: CURE PHARMACEUTICAL HOLDING CORP.
    Inventor: Gary J. Speier
  • Publication number: 20200215137
    Abstract: The present invention provides for methods of obtaining an extract of Cannabis plant material as well as subsequent processing of the extract to provide a concentrate of Cannabis. The present invention also provides for pharmaceutical dosage forms (e.g., oral thin films and transdermal patches) that include the concentrate (or extract) of Cannabis, as well as methods of medical treatment that include administering the pharmaceutical dosage forms.
    Type: Application
    Filed: March 5, 2020
    Publication date: July 9, 2020
    Applicant: CURE PHARMACEUTICAL HOLDING CORP.
    Inventor: Gary J. Speier
  • Publication number: 20200197466
    Abstract: The present invention provides for methods of obtaining an extract of Cannabis plant material as well as subsequent processing of the extract to provide a concentrate of Cannabis. The present invention also provides for pharmaceutical dosage forms (e.g., oral thin films and transdermal patches) that include the concentrate (or extract) of Cannabis, as well as methods of medical treatment that include administering the pharmaceutical dosage forms.
    Type: Application
    Filed: March 5, 2020
    Publication date: June 25, 2020
    Applicant: CURE PHARMACEUTICAL HOLDING CORP
    Inventor: Gary J. Speier
  • Patent number: 10639339
    Abstract: The present invention provides for methods of obtaining an extract of Cannabis plant material as well as subsequent processing of the extract to provide a concentrate of Cannabis. The present invention also provides for pharmaceutical dosage forms (e.g., oral thin films and transdermal patches) that include the concentrate (or extract) of Cannabis, as well as methods of medical treatment that include administering the pharmaceutical dosage forms.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: May 5, 2020
    Assignee: CURE PHARMACEUTICAL HOLDING CORP.
    Inventor: Gary J. Speier
  • Patent number: 10624940
    Abstract: The present invention provides for methods of obtaining an extract of Cannabis plant material as well as subsequent processing of the extract to provide a concentrate of Cannabis. The present invention also provides for pharmaceutical dosage forms (e.g., oral thin films and transdermal patches) that include the concentrate (or extract) of Cannabis, as well as methods of medical treatment that include administering the pharmaceutical dosage forms.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: April 21, 2020
    Assignee: CURE PHARMACEUTICAL HOLDING CORP.
    Inventor: Gary J. Speier
  • Patent number: 10238705
    Abstract: The present invention provides for methods of obtaining an extract of Cannabis plant material as well as subsequent processing of the extract to provide a concentrate of Cannabis. The present invention also provides for pharmaceutical dosage forms (e.g., oral thin films and transdermal patches) that include the concentrate (or extract) of Cannabis, as well as methods of medical treatment that include administering the pharmaceutical dosage forms.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: March 26, 2019
    Assignee: CURE PHARMACEUTICAL HOLDING CORP.
    Inventor: Gary J. Speier
  • Patent number: 10092611
    Abstract: The present invention provides for methods of obtaining an extract of Cannabis plant material as well as subsequent processing of the extract to provide a concentrate of Cannabis. The present invention also provides for pharmaceutical dosage forms (e.g., oral thin films and transdermal patches) that include the concentrate (or extract) of Cannabis, as well as methods of medical treatment that include administering the pharmaceutical dosage forms.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: October 9, 2018
    Assignee: CURE PHARMACEUTICAL HOLDING CORP.
    Inventor: Gary J. Speier